玫瑰红photodynamic抗菌治疗与局部抗真菌药在真菌性角膜炎分离株中的光化学相互作用
本研究评估玫瑰红(RB)光动力抗菌治疗(PDAT)与两性霉素B、那他霉素和伏立康唑联用对临床镰刀菌和曲霉菌分离株的体外效果。结果显示镰刀菌比曲霉菌对RB-PDAT更敏感;与伏立康唑联用增加生长抑制且伏立康唑保持稳定,而与那他霉素联用抑制降低且那他霉素完全降解,与两性霉素B联用两性霉素B降解70%。
要点
- 镰刀菌分离株对RB-PDAT的敏感性高于曲霉菌分离株。
- RB-PDAT与伏立康唑联用增加生长抑制,且伏立康唑保持稳定。
- RB-PDAT与那他霉素联用降低生长抑制,且那他霉素完全降解。
核心结论
- 镰刀菌和曲霉菌分离株对联合RB-PDAT的抗真菌治疗反应呈菌株特异性。
- 伏立康唑与RB-PDAT联用时真菌抑制增加且保持稳定,提示其与RB-PDAT的潜在相容性。
- 那他霉素与两性霉素B在RB-PDAT下抑制降低并发生降解,提示整合RB-PDAT时需考虑药物稳定性。
研究设计与样本
- 体外研究,使用临床镰刀菌属(n=3)和曲霉菌属(n=3)分离株,采用标准微生物学技术培养。
主要发现
- 总体而言,镰刀菌分离株对RB-PDAT比曲霉菌分离株更敏感。
- RB-PDAT联合那他霉素与抗真菌单药治疗相比降低生长抑制。
- RB-PDAT联合伏立康唑与抗真菌单药治疗相比增加生长抑制。
- 紫外-可见光谱显示与RB-PDAT联合时两性霉素B降解70%,那他霉素完全降解,而伏立康唑保持稳定。
关键数值与推荐
- 琼脂平板含三种浓度的两性霉素B、那他霉素或伏立康唑,并设无抗真菌药平板。
- 测试组包括抗真菌单药、RB单药及抗真菌与RB联合治疗,均在黑暗和光照条件下进行。
- 平板孵育7天后量化生长抑制百分比。
临床怎么用
- 在真菌性角膜炎管理中整合RB-PDAT时,可优先考虑与伏立康唑联用以增加抑制且保持药物稳定。
- 与那他霉素或两性霉素B联用需注意药物降解可能降低疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to evaluate the in vitro effects of combining rose bengal (RB) photodynamic antimicrobial therapy (PDAT) with conventional topical antifungals (amphotericin B, natamycin, and voriconazole) on clinical Fusarium and Aspergillus isolates and to determine the antifungal stability under experimental conditions. METHODS: Clinical isolates of Fusarium spp. (n = 3) and Aspergillus spp. (n = 3) were cultured using standard microbiology techniques. Agar plates were prepared with three concentrations of amphotericin B, natamycin, or voriconazole along with plates containing no antifungals. The following groups were tested in both dark and light conditions: (1) antifungal monotherapy (antifungal only), (2) RB monotherapy (RB only), and (3) antifungal and RB combination therapy. Plates were incubated for 7 days and percent growth inhibition was quantified. UV-visible spectroscopy and mass spectrometry was performed to assess antifungal stability. RESULTS: Overall, Fusarium isolates were more susceptible to RB-PDAT than Aspergillus isolates. RB-PDAT combination therapy with natamycin reduced growth inhibition, whereas combination therapy with voriconazole increased growth inhibition compared to antifungal monotherapy. UV-visible spectroscopy demonstrated 70% degradation of amphotericin B and full degradation of natamycin when combined with RB-PDAT, whereas voriconazole remained stable. CONCLUSIONS: Across both Fusarium and Aspergillus isolates, treatment responses to antifungals with or without RB-PDAT demonstrated strain-specific effects. The increased fungal inhibition and maintained stability of voriconazole when combined with RB-PDAT highlight its potential compatibility with RB-PDAT. In contrast, the reduced inhibition and degradation of natamycin and amphotericin B with RB-PDAT suggests that drug stability may be a factor to consider when integrating RB-PDAT into fungal keratitis management.
引用
- Krishna K, Chou B, Gonzalez L, et al. Evaluating Photochemical Interactions Between Rose Bengal Photodynamic Antimicrobial Therapy and Topical Antifungals in Fungal Keratitis Isolates. Invest Ophthalmol Vis Sci. 2026. PMID: 41533911. doi:10.1167/iovs.67.1.11
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。